Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

BVS

Bioventus Inc

May 02 • 04:00PM ET

3.96

Dollar change -0.03
Percentage change -0.75	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF SCHA IWC ONEQ AVSC DFAS SCHB DFUS DCOR

Index	-	P/E	-	EPS (ttm)	-2.51	Insider Own	43.27%	Shs Outstand	63.27M	Perf Week	-2.70%
Market Cap	252.77M	Forward P/E	10.51	EPS next Y	0.38	Insider Trans	-0.07%	Shs Float	36.21M	Perf Month	-21.12%
Income	-156.23M	PEG	-	EPS next Q	-0.07	Inst Own	31.77%	Short Float	2.46%	Perf Quarter	-13.91%
Sales	512.35M	P/S	0.49	EPS this Y	683.34%	Inst Trans	2.05%	Short Ratio	6.30	Perf Half Y	6.17%
Book/sh	2.74	P/B	1.44	EPS next Y	140.43%	ROA	-8.86%	Short Interest	0.89M	Perf Year	312.24%
Cash/sh	0.58	P/C	6.84	EPS next 5Y	-	ROE	-39.47%	52W Range	0.86 - 6.08	Perf YTD	-24.86%
Dividend Est.	-	P/FCF	31.68	EPS past 5Y	-51.10%	ROI	-28.35%	52W High	-34.87%	Beta	0.63
Dividend TTM	-	Quick Ratio	1.01	Sales past 5Y	10.81%	Gross Margin	62.33%	52W Low	360.47%	ATR (14)	0.22
Dividend Ex-Date	-	Current Ratio	1.53	EPS Y/Y TTM	2.47%	Oper. Margin	3.30%	RSI (14)	29.38	Volatility	4.74% 4.92%
Employees	970	Debt/Eq	2.36	Sales Y/Y TTM	0.04%	Profit Margin	-30.49%	Recom	2.33	Target Price	6.50
Option/Short	Yes / Yes	LT Debt/Eq	2.18	EPS Q/Q	81.26%	Payout	-	Rel Volume	0.42	Prev Close	3.99
Sales Surprise	9.25%	EPS Surprise	266.49%	Sales Q/Q	7.62%	Earnings	May 07 BMO	Avg Volume	141.50K	Price	3.96
SMA20	-12.42%	SMA50	-19.02%	SMA200	-5.83%	Trades		Volume	59,221	Change	-0.75%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-07-23	Upgrade	Canaccord Genuity	Hold → Buy	$7
Aug-09-23	Upgrade	Craig Hallum	Hold → Buy	$4 → $6
Nov-22-22	Downgrade	Craig Hallum	Buy → Hold
Nov-09-22	Downgrade	JP Morgan	Overweight → Underweight
Nov-09-22	Downgrade	Canaccord Genuity	Buy → Hold	$18 → $6
Mar-15-22	Initiated	Craig Hallum	Buy	$30
Nov-15-21	Resumed	Morgan Stanley	Overweight	$20
Nov-10-21	Resumed	JP Morgan	Overweight	$25
Jul-01-21	Downgrade	Goldman	Buy → Neutral	$20 → $19
Mar-08-21	Initiated	Morgan Stanley	Overweight	$18
Mar-08-21	Initiated	JP Morgan	Overweight	$17
Mar-08-21	Initiated	Goldman	Buy	$19
Mar-08-21	Initiated	Canaccord Genuity	Buy	$23

Show Previous Ratings

Apr-29-24 07:30AM	Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024 (GlobeNewswire)
Mar-13-24 08:48AM	Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript (Insider Monkey) -5.54%
Mar-12-24 10:20PM	Q4 2023 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +5.46%
09:11AM	Bioventus Inc (BVS) Reports Growth in Q4 Sales and Adjusted EBITDA, Provides Optimistic 2024 ... (GuruFocus.com)
07:30AM	Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
08:00AM	Loading…
Mar-04-24 08:00AM	Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024 (GlobeNewswire)
Jan-18-24 04:15PM	Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility (GlobeNewswire)
Jan-12-24 04:15PM	Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole (GlobeNewswire)
Dec-19-23 04:30PM	Bioventus Names Robert Claypoole as President and Chief Executive Officer (GlobeNewswire)
Dec-06-23 08:00AM	Bioventus Agrees to Nationwide Contract with Aetna Medicare Advantage Plans for DUROLANE for Knee Osteoarthritis (GlobeNewswire)
Nov-27-23 01:33AM	Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant (MedTech Dive)
Nov-12-23 09:02AM	Bioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 07:59AM	Bioventus Inc (BVS) Reports Q3 2023 Financial Results, Raises Full Year 2023 Financial Guidance (GuruFocus.com)
07:00AM	Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance (GlobeNewswire)
Oct-31-23 07:00AM	Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023 (GlobeNewswire) +5.37%
10:48AM	Loading…
Oct-25-23 10:48AM	Bioventus (BVS) to Report Q3 Earnings: What's in the Cards? (Zacks)
Sep-28-23 07:43AM	3 Value Medical Stocks to Buy for Safety Amid Market Volatility (Zacks)
Sep-19-23 09:52PM	Bioventus to Present at the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-06-23 04:30PM	Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-16-23 09:02AM	Juniper Investment Company, LLC Increases Stake in Bioventus Inc (GuruFocus.com) -5.26%
Aug-10-23 08:09AM	Bioventus works to trim debt under interim CEO (American City Business Journals) +11.74%
Aug-08-23 10:02PM	Q2 2023 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +14.12%
07:30AM	Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance (GlobeNewswire)
Aug-04-23 08:30AM	Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference (GlobeNewswire)
Aug-01-23 05:35PM	Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023 (GlobeNewswire)
Jun-23-23 06:35PM	Madrigal Pharmaceuticals and Bioventus Stock See Action From Activist Investors (Barrons.com)
May-25-23 06:38AM	Daily Vickers Top Buyers & Sellers for 05/25/2023 (Argus Research)
May-23-23 07:30AM	Bioventus Completes Divestiture of its Wound Business (GlobeNewswire) +16.27%
May-18-23 12:07PM	Bioventus Inc. (NASDAQ:BVS) Q1 2023 Earnings Call Transcript (Insider Monkey) +11.45%
May-17-23 08:33AM	Q1 2023 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +9.17%
04:15PM	Loading…
May-16-23 04:15PM	Bioventus Reports First Quarter Financial Results (GlobeNewswire)
May-15-23 05:33PM	Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023 (GlobeNewswire)
May-11-23 07:00AM	Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023 (GlobeNewswire) +17.48%
May-10-23 09:00AM	Bioventus Announces Divestiture of its Wound Business (GlobeNewswire) +6.95%
May-03-23 08:30AM	Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023 (GlobeNewswire)
Apr-08-23 08:55AM	While institutions invested in Bioventus Inc. (NASDAQ:BVS) benefited from last week's 22% gain, private equity firms stood to gain the most (Simply Wall St.)
Apr-05-23 10:52AM	Bioventus Inc. (NASDAQ:BVS) Q4 2022 Earnings Call Transcript (Insider Monkey) +12.73%
08:00AM	Bioventus Announces CEO Leadership Change (GlobeNewswire)
07:38AM	New Strong Sell Stocks for April 5th (Zacks)
Mar-31-23 07:30AM	Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results (GlobeNewswire) -11.57%
07:00AM	Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility (GlobeNewswire)
Mar-30-23 04:51AM	Heres Why Bioventus (BVS) Declined in Q4 (Insider Monkey)
Mar-29-23 08:55AM	Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023 (GlobeNewswire)
Mar-20-23 10:16AM	Are Options Traders Betting on a Big Move in Bioventus (BVS) Stock? (Zacks)
Mar-16-23 08:30AM	Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023 (GlobeNewswire) -12.88%
Feb-28-23 07:30AM	Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition (GlobeNewswire) +45.89%
Jan-27-23 02:49PM	Bioventus to divest assets ahead of major payments coming due (American City Business Journals)
Jan-14-23 03:14PM	15 Largest Orthopedic Companies in the World (Insider Monkey)
Jan-04-23 07:00AM	Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-27-22 02:53PM	2022 Year in Review: Layoffs hit Triangle biotech, pharma companies (American City Business Journals)
Dec-09-22 11:58AM	Durham's Bioventus slashing headcount to rein in expenses (American City Business Journals)
Nov-28-22 10:34PM	Why this Durham firm's stock is down more than 70% this month (American City Business Journals) -20.41%
Nov-21-22 05:15PM	Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance (GlobeNewswire)
Nov-16-22 05:15PM	Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022 (GlobeNewswire) -9.45%
Nov-10-22 05:38AM	Bioventus Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.) +25.58%
Nov-09-22 06:18PM	Why Shares of Bioventus Fell 14% on Wednesday (Motley Fool) -14.00%
Nov-08-22 07:30AM	Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance (GlobeNewswire) -57.51%
Oct-31-22 07:00AM	Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022 (GlobeNewswire)
Oct-12-22 08:00AM	Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago (GlobeNewswire)
Aug-30-22 08:00AM	Bioventus to Present at the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-12-22 02:32AM	Bioventus Inc. (BVS) Q2 2022 Earnings Call Transcript (Motley Fool) +7.84%
Aug-11-22 07:00AM	Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance (GlobeNewswire)
Aug-03-22 07:00AM	Bioventus Receives FDA 510(k) Clearance for SonaStar Elite (GlobeNewswire)
Jul-26-22 07:00AM	Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022 (GlobeNewswire)
Jul-12-22 08:30AM	Bioventus Completes CartiHeal Acquisition (GlobeNewswire) +9.67%
Jul-04-22 10:00AM	Investors one-year losses grow to 57% as the stock sheds US$66m this past week (Simply Wall St.)
Jun-22-22 05:00AM	Durham firm reworks $450M acquisition amid stock market volatility (American City Business Journals)
Jun-21-22 07:30AM	Bioventus Amends CartiHeal Acquisition Structure (GlobeNewswire) -5.04%
Jun-15-22 08:33AM	Implied Volatility Surging for Bioventus (BVS) Stock Options (Zacks)
May-10-22 01:00PM	Bioventus Inc. (BVS) Q1 2022 Earnings Call Transcript (Motley Fool)
07:00AM	Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance (GlobeNewswire)
May-04-22 02:54PM	With markets shaky, Durham firm scraps $415M plan to fund acquisition (American City Business Journals) -10.41%
05:56AM	U.K. Companies Borrowing Costs Surge Past Covid-19 Pandemic Peak (Bloomberg)
May-03-22 05:47PM	Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance (GlobeNewswire)
01:57PM	Fearful Investors Should Buy Credit, Sell Stocks, JPMorgan Says (Bloomberg)
May-02-22 07:00AM	Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis (GlobeNewswire) -8.56%
Apr-26-22 02:59PM	Durham company needs to raise $415M for deal. Here's how it's doing it. (American City Business Journals)
09:05AM	Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA (GlobeNewswire)
08:38AM	Bioventus Announces $415 Million Offering of Senior Notes (GlobeNewswire)
Apr-25-22 07:00AM	Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022 (GlobeNewswire)
Apr-08-22 09:15AM	Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives (GlobeNewswire)
Apr-07-22 10:12PM	Some Investors May Be Worried About Bravura Solutions' (ASX:BVS) Returns On Capital (Simply Wall St.)
Apr-05-22 07:00AM	Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton (GlobeNewswire)
Apr-04-22 05:36PM	Bioventus Inc. (NASDAQ:BVS) Shares Could Be 47% Below Their Intrinsic Value Estimate (Simply Wall St.)
02:23PM	Durham public company adds to acquisition streak with $450M deal (American City Business Journals)
11:27AM	Why Bioventus Stock Is Sinking Today (Motley Fool)
07:00AM	Bioventus Exercises Call Option to Acquire CartiHeal (GlobeNewswire)
Apr-03-22 09:10PM	3 Strong Buy Stocks to Watch as 2Q22 Kicks Off (TipRanks)
Mar-25-22 07:32AM	Making a market: Why Charlotte suddenly emerged last year as NCs driving force for IPOs (American City Business Journals)
Mar-16-22 07:00AM	Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference (GlobeNewswire)
Mar-11-22 09:43AM	Company News for Mar 11, 2022 (Zacks)
Mar-10-22 12:30PM	Bioventus Inc. (BVS) Q4 2021 Earnings Call Transcript (Motley Fool)
07:00AM	Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance (GlobeNewswire)
Mar-01-22 07:00AM	Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device (GlobeNewswire)
Feb-28-22 11:29AM	TBJ Plus: Durham firm adds Duke grad to C-suite; Triangle county has NC's lowest closing costs; Bucs co-owner sells mansion for $53M (American City Business Journals)
07:00AM	Bioventus Appoints Mark Singleton as Chief Financial Officer (GlobeNewswire)
Feb-22-22 07:00AM	Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022 (GlobeNewswire)
Feb-09-22 07:35AM	SWK Holdings Provides Portfolio Update Highlighting Recent Achievements (PR Newswire)
Feb-07-22 03:38PM	Royce Investment Partners Buys H&R Block Inc, Louisiana-Pacific Corp, Forward Air Corp, ... (GuruFocus.com)
Feb-03-22 05:52AM	A number of insiders bought Bioventus Inc. (NASDAQ:BVS) stock last year, which is great news for shareholders (Simply Wall St.)

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Singleton Mark Leonard	SVP & CFO	Apr 11 '24	Sale	4.75	4,000	19,000	34,665	Apr 15 06:03 PM
D'Adamio Anthony	SVP & General Counsel	Apr 11 '24	Sale	4.75	3,054	14,506	58,242	Apr 15 06:00 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Apr 11 '24	Sale	4.75	1,325	6,294	17,042	Apr 15 05:58 PM
Singleton Mark Leonard	SVP & CFO	Mar 22 '24	Sale	5.39	5,541	29,853	25,665	Mar 25 05:36 PM
D'Adamio Anthony	SVP & General Counsel	Mar 15 '24	Sale	5.46	3,125	17,062	51,371	Mar 20 06:41 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Mar 15 '24	Sale	5.46	1,217	6,645	14,067	Mar 20 06:41 PM
Bihl Anthony P III	Interim CEO	Aug 18 '23	Buy	4.14	26,595	110,071	26,595	Aug 22 06:20 PM
Bihl Anthony P III	Interim CEO	Aug 18 '23	Buy	4.14	13,290	55,005	138,290	Aug 22 06:20 PM
Juniper Investment Company, LL	10% Owner	Aug 14 '23	Buy	4.79	14,985	71,778	6,833,857	Aug 15 04:05 PM
Bartholdson John A.	Director	Aug 14 '23	Buy	4.79	14,985	71,753	6,833,857	Aug 15 05:48 PM
Bartholdson John A.	Director	Aug 11 '23	Buy	4.60	50,037	229,935	6,818,872	Aug 15 05:48 PM
Juniper Investment Company, LL	10% Owner	Aug 11 '23	Buy	4.56	50,037	228,169	6,818,872	Aug 15 04:05 PM
Bartholdson John A.	Director	Aug 10 '23	Buy	4.47	111,848	500,419	6,768,835	Aug 14 06:04 PM
Juniper Investment Company, LL	10% Owner	Aug 10 '23	Buy	4.47	111,848	499,961	6,768,835	Aug 15 04:05 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Jul 03 '23	Sale	2.83	394	1,115	11,828	Jul 05 05:11 PM
Ladone Mary Kay	Director	Jun 16 '23	Option Exercise	0.00	1,813	0	20,274	Jun 20 05:34 PM
McMurry-Heath Michelle	Director	Jun 16 '23	Option Exercise	0.00	386	0	17,419	Jun 20 05:21 PM
Beyer Pat	Director	Jun 16 '23	Option Exercise	0.00	965	0	18,578	Jun 20 05:08 PM
Bartholdson John A.	Director	Jun 15 '23	Buy	3.61	110,180	397,662	6,656,987	Jun 16 04:30 PM
Bartholdson John A.	Director	Jun 14 '23	Buy	3.24	181,946	589,523	6,546,807	Jun 16 04:30 PM
Bartholdson John A.	Director	Jun 13 '23	Buy	3.05	60,324	183,910	6,364,861	Jun 14 05:54 PM
Bartholdson John A.	Director	Jun 12 '23	Buy	2.92	395,401	1,154,255	6,304,537	Jun 14 05:54 PM
SUTTER MARTIN P	Director	Jun 06 '23	Option Exercise	0.00	16,648	0	28,348	Jun 13 05:12 PM
NEELS GUIDO J	Director	Jun 06 '23	Option Exercise	0.00	16,648	0	28,348	Jun 08 07:32 PM
McMurry-Heath Michelle	Director	Jun 06 '23	Option Exercise	0.00	16,648	0	17,033	Jun 08 07:21 PM
Ladone Mary Kay	Director	Jun 06 '23	Option Exercise	0.00	16,648	0	18,461	Jun 08 07:08 PM
HAWKINS WILLIAM A	Director	Jun 06 '23	Option Exercise	0.00	16,648	0	200,958	Jun 08 06:57 PM
Beyer Pat	Director	Jun 06 '23	Option Exercise	0.00	16,648	0	17,613	Jun 08 06:45 PM
Bartholdson John A.	Director	Jun 06 '23	Option Exercise	0.00	7,576	0	7,576	Jun 08 06:27 PM
STALNECKER SUSAN M	Director	Jun 06 '23	Option Exercise	0.00	16,648	0	49,064	Jun 08 07:55 PM
NOHRA GUY P	Director	Jun 06 '23	Option Exercise	0.00	16,648	0	28,348	Jun 08 07:42 PM
HAWKINS WILLIAM A	Director	May 25 '23	Buy	2.66	44,000	117,176	184,310	May 26 04:28 PM
HAWKINS WILLIAM A	Director	May 24 '23	Buy	2.69	44,000	118,391	140,310	May 26 04:28 PM
Bihl Anthony P III	Interim CEO	May 23 '23	Buy	2.33	125,000	290,988	125,000	May 24 09:17 PM
Bartholdson John A.	Director	May 22 '23	Buy	2.08	178,998	372,298	5,909,136	May 23 09:16 PM
Bartholdson John A.	Director	May 19 '23	Buy	1.94	1,136,675	2,200,830	5,730,138	May 23 09:16 PM

Open in Screener

LDOS

Leidos Holdings Inc

May 02 • 04:00PM ET

142.66

Dollar change +0.47
Percentage change 0.33	%

Technology • Information Technology Services • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

LDOS Leidos Holdings Inc daily Stock Chart

Held by: VTI VOO VB CIBR IVV VO VBR RSP VTV JEPI

Index	S&P 500	P/E	61.49	EPS (ttm)	2.32	Insider Own	1.21%	Shs Outstand	135.77M	Perf Week	9.84%
Market Cap	19.28B	Forward P/E	15.83	EPS next Y	9.01	Insider Trans	-1.44%	Shs Float	133.50M	Perf Month	10.58%
Income	321.00M	PEG	6.51	EPS next Q	2.09	Inst Own	77.32%	Short Float	1.06%	Perf Quarter	28.70%
Sales	15.71B	P/S	1.23	EPS this Y	14.23%	Inst Trans	-1.75%	Short Ratio	1.48	Perf Half Y	43.93%
Book/sh	31.52	P/B	4.53	EPS next Y	8.05%	ROA	2.47%	Short Interest	1.42M	Perf Year	76.98%
Cash/sh	5.53	P/C	25.81	EPS next 5Y	9.45%	ROE	7.41%	52W Range	76.58 - 142.90	Perf YTD	31.80%
Dividend Est.	1.54 (1.08%)	P/FCF	16.90	EPS past 5Y	-17.61%	ROI	3.42%	52W High	-0.17%	Beta	0.69
Dividend TTM	1.48 (1.04%)	Quick Ratio	1.24	Sales past 5Y	8.68%	Gross Margin	15.19%	52W Low	86.29%	ATR (14)	2.66
Dividend Ex-Date	Jun 14, 2024	Current Ratio	1.35	EPS Y/Y TTM	-51.92%	Oper. Margin	9.24%	RSI (14)	84.21	Volatility	2.50% 1.87%
Employees	47000	Debt/Eq	1.22	Sales Y/Y TTM	7.62%	Profit Margin	2.04%	Recom	1.65	Target Price	153.05
Option/Short	Yes / Yes	LT Debt/Eq	1.21	EPS Q/Q	76.59%	Payout	101.25%	Rel Volume	1.77	Prev Close	142.19
Sales Surprise	4.10%	EPS Surprise	34.80%	Sales Q/Q	7.46%	Earnings	Apr 30 BMO	Avg Volume	959.61K	Price	142.66
SMA20	10.90%	SMA50	11.19%	SMA200	31.54%	Trades		Volume	1,697,922	Change	0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-24	Upgrade	Barclays	Equal Weight → Overweight
Nov-17-23	Upgrade	Argus	Hold → Buy
May-25-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$87 → $102
Mar-27-23	Downgrade	Jefferies	Buy → Hold	$120 → $95
Dec-08-22	Initiated	Citigroup	Buy	$130
Aug-30-22	Initiated	RBC Capital Mkts	Sector Perform	$106
Jun-07-22	Downgrade	Barclays	Overweight → Equal Weight	$105
Mar-24-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$97 → $113
Mar-18-22	Resumed	Stifel	Buy	$126
Aug-20-21	Downgrade	Argus	Buy → Hold
May-21-21	Resumed	Citigroup	Buy	$120
May-13-21	Initiated	Wells Fargo	Overweight	$120
Apr-05-21	Upgrade	Goldman	Neutral → Buy	$111 → $116
Sep-23-20	Upgrade	Barclays	Equal Weight → Overweight	$109 → $110
Sep-22-20	Upgrade	JP Morgan	Neutral → Overweight	$115
Aug-21-20	Initiated	Evercore ISI	Outperform
May-07-20	Resumed	Credit Suisse	Outperform	$133
Apr-20-20	Upgrade	Citigroup	Neutral → Buy	$115
Mar-31-20	Initiated	William Blair	Outperform
Mar-03-20	Upgrade	Wells Fargo	Equal Weight → Overweight	$120

Show Previous Ratings

May-01-24 02:19PM	Final Trades: Crowdstrike, ONEOK and Leidos Holdings (CNBC TV)
11:40AM	Leidos Holdings, Inc. (NYSE:LDOS) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:27AM	Truist Adjusts Price Target on Leidos Holdings to $165 From $150 (MT Newswires)
11:19AM	Leidos Awarded $206 Million National Geospatial-Intelligence Agency Contract (MT Newswires)
11:19AM	RBC Capital Adjusts Price Target on Leidos Holdings to $140 From $120 (MT Newswires)
10:59AM	Loading…
10:59AM	TD Cowen Adjusts Price Target on Leidos Holdings to $155 From $140 (MT Newswires)
10:57AM	Stifel Adjusts Price Target on Leidos Holdings to $160 From $138 (MT Newswires)
10:57AM	Citigroup Adjusts Price Target on Leidos Holdings to $165 From $141 (MT Newswires)
10:27AM	Goldman Sachs Adjusts Price Target on Leidos to $165 From $150 (MT Newswires)
09:15AM	Leidos Holdings, Inc. (LDOS) Hits Fresh High: Is There Still Room to Run? (Zacks)
08:00AM	Leidos awarded $206M NGA mission software modernization contract (PR Newswire)
07:24AM	Wells Fargo Adjusts Leidos Holdings Price Target to $158 From $147 (MT Newswires)
03:03AM	Leidos Holdings Inc (LDOS) Q1 2024 Earnings Call Transcript Highlights: Strong Performance and ... (GuruFocus.com)
Apr-30-24 04:41PM	S&P 500 Gains and Losses Today: GE HealthCare Stock Plunges After Earnings Miss (Investopedia) +6.53%
10:55AM	LDOS Stock Earnings: Leidos Holdings Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
10:40AM	Loading…
10:40AM	Why Leidos Stock Is Higher Today (Motley Fool)
09:30AM	Leidos (LDOS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:28AM	Leidos Holdings' Fiscal Q1 Non-GAAP Earnings, Revenue Advance; Fiscal 2024 Guidance Lifted -- Shares Jump Pre-Bell (MT Newswires)
09:26AM	Leidos Holdings (LDOS) Beats on Q1 Earnings, Ups '24 EPS View (Zacks)
07:32AM	Leidos Holdings Inc. (LDOS) Q1 Earnings: Surpasses Analyst Revenue Forecasts (GuruFocus.com)
06:41AM	Leidos lifts 2024 forecasts on defense demand (Reuters)
06:04AM	Leidos: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Leidos Holdings, Inc. Reports First Quarter Fiscal Year 2024 Results (PR Newswire)
Apr-26-24 05:50PM	Leidos (LDOS) Advances But Underperforms Market: Key Facts (Zacks)
04:15PM	Leidos Holdings, Inc. Declares Quarterly Cash Dividend (PR Newswire)
Apr-24-24 06:00PM	Leidos (LDOS) Rises Higher Than Market: Key Facts (Zacks)
01:27PM	Leidos (LDOS) to Report Q1 Earnings: What's in the Cards? (Zacks)
09:00AM	Is Most-Watched Stock Leidos Holdings, Inc. (LDOS) Worth Betting on Now? (Zacks)
Apr-23-24 10:00AM	Leidos (LDOS) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-19-24 09:30AM	Wall Street Analysts See Leidos (LDOS) as a Buy: Should You Invest? (Zacks)
06:00PM	Loading…
Apr-18-24 06:00PM	Leidos (LDOS) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Apr-17-24 09:40AM	Why Leidos (LDOS) is a Top Value Stock for the Long-Term (Zacks)
Apr-15-24 08:00AM	Leidos awarded $267 million Army C5ISR and COTS systems task order (PR Newswire)
Apr-12-24 06:00PM	Leidos (LDOS) Stock Moves -0.72%: What You Should Know (Zacks)
02:48PM	Trade Tracker: Honeywell, Freeport-McMoran, Leidos Holdings, Cisco, McDonald's, Netflix (CNBC TV)
Apr-11-24 12:10PM	Will Leidos (LDOS) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:45AM	Here's Why Leidos (LDOS) is a Strong Growth Stock (Zacks)
09:40AM	Is Leidos (LDOS) Stock Outpacing Its Aerospace Peers This Year? (Zacks)
Apr-09-24 08:00AM	Leidos selected for Army National Guard aviation training contract (PR Newswire)
Apr-08-24 06:15PM	Why the Market Dipped But Leidos (LDOS) Gained Today (Zacks)
Apr-05-24 11:48AM	Military Cyber Security market is projected to grow at a CAGR of 7.6% by 2034: Visiongain (GlobeNewswire)
Apr-02-24 08:00AM	Leidos Schedules First Quarter 2024 Earnings Conference Call for April 30, 2024, at 8 a.m. (ET) (PR Newswire)
Mar-29-24 08:00AM	Leidos-designed low-profile vessels participate in U.S. Army's Project Convergence Capstone 4 exercise (PR Newswire)
Mar-28-24 08:00AM	Leidos Partnership deploys electronic health record system to joint DOD-VA federal health care site (PR Newswire)
Mar-26-24 09:45AM	Why Leidos (LDOS) is a Top Growth Stock for the Long-Term (Zacks)
Mar-25-24 10:15AM	Leidos (LDOS) Builds Air Traffic Management Center in Singapore (Zacks)
Mar-22-24 09:50AM	Here's Why Leidos (LDOS) is a Strong Momentum Stock (Zacks)
Mar-21-24 10:41AM	Is Leidos (LDOS) Outperforming Other Aerospace Stocks This Year? (Zacks)
Mar-20-24 08:00AM	Leidos Establishes Air Traffic Management Office in Indo-Pacific Region (PR Newswire)
08:00AM	Leidos Establishes Air Traffic Management Center of Excellence in Indo-Pacific Region (PR Newswire)
Mar-18-24 01:55PM	Final Trades: Leidos Holdings, CrowdStrike, Paccar and GSG (CNBC TV)
Mar-15-24 10:10AM	Reasons to Add Leidos (LDOS) to Your Portfolio Right Now (Zacks)
Mar-14-24 11:30AM	Why Is Leidos (LDOS) Up 5.4% Since Last Earnings Report? (Zacks)
Mar-11-24 08:32AM	Leidos (LDOS) Wins $158M Contract for Command-and-Control Systems (Zacks)
Mar-07-24 04:00PM	Leidos awarded $158 million U.S. Air Force command and control emergency management contract (PR Newswire)
Mar-06-24 09:50AM	Why Leidos (LDOS) is a Top Momentum Stock for the Long-Term (Zacks)
08:00AM	Leidos Announces Strategic Collaboration Agreement with AWS (PR Newswire)
Mar-05-24 12:00PM	What Makes Leidos (LDOS) a Strong Momentum Stock: Buy Now? (Zacks)
08:00AM	Leidos to Participate in the J.P. Morgan 2024 Industrials Conference (PR Newswire)
Mar-04-24 08:00AM	Leidos Named to World's Most Ethical Companies List for Seventh Consecutive Year (PR Newswire)
Feb-28-24 09:40AM	Here's Why Leidos (LDOS) is a Strong Value Stock (Zacks)
Feb-23-24 02:05PM	Final Trades: Walmart, Star Bulk Carrier, Leidos Holdings and Intuit (CNBC TV)
Feb-22-24 11:29PM	Leidos Holdings Inc Director Gary May Sells 2,745 Shares (GuruFocus.com)
Feb-21-24 02:55PM	Final Trades: Leidos Holdings, General Motors, Amplify Cybersecurity ETF and CME Group (CNBC TV)
Feb-16-24 02:31PM	Final Trades: Leidos Holdings, Vulcan Materials and IDU (CNBC TV)
Feb-15-24 08:00AM	Leidos Awarded $143M DIA Technology Platform Contract (PR Newswire)
Feb-14-24 11:52PM	Top 20 Defense Contractors in 2024 (Insider Monkey)
02:22PM	Final Trades: Leidos Holdings, Disney, NextEra Energy and Progressive (CNBC TV)
09:09AM	Leidos Holdings, Inc. (NYSE:LDOS) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:28AM	Q4 2023 Leidos Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-13-24 09:45AM	Leidos Holdings (LDOS) Q4 Earnings Top, Revenues Rise Y/Y (Zacks) +5.87%
09:30AM	Compared to Estimates, Leidos (LDOS) Q4 Earnings: A Look at Key Metrics (Zacks)
07:20AM	Leidos sees 2024 profit largely above Wall Street on defense demand (Reuters)
07:10AM	Leidos (LDOS) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:34AM	Leidos Holdings Inc (LDOS) Reports Strong Revenue Growth Amidst Earnings Challenges (GuruFocus.com)
06:17AM	Leidos: Q4 Earnings Snapshot (Associated Press Finance)
06:17AM	Leidos Holdings Guides FY24 In Line With Estimates - Update (RTT News)
06:00AM	Leidos Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results (PR Newswire)
Feb-12-24 09:40AM	Why Leidos (LDOS) is a Top Value Stock for the Long-Term (Zacks)
Feb-08-24 04:15PM	Leidos Holdings, Inc. Declares Quarterly Cash Dividend (PR Newswire)
04:00PM	Leidos and Sourcegraph to bring secure, AI-enabled software development to government customers (PR Newswire)
09:31AM	Will High Interest Expense Hurt Leidos' (LDOS) Q4 Earnings? (Zacks)
09:15AM	Countdown to Leidos (LDOS) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
08:00AM	Leidos to Participate in Citi's 2024 Global Industrial Tech and Mobility Conference (PR Newswire)
Feb-06-24 10:00AM	Leidos (LDOS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-02-24 09:40AM	Are Investors Undervaluing Leidos (LDOS) Right Now? (Zacks)
Jan-30-24 07:07AM	If You Love America's New Robot Navy, Buy This 1 Stock (Motley Fool)
Jan-29-24 04:30PM	Leidos awarded contract to support ARPA-H (PR Newswire)
08:00AM	Leidos to Participate in the TD Cowen 45th Annual Aerospace & Defense Conference (PR Newswire)
Jan-25-24 12:10PM	Will Leidos (LDOS) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-22-24 08:00AM	Advanced Multilayered Mobile Force Protection Excels at MFIX Demo (PR Newswire)
06:00AM	Bull of the Day: Leidos Holdings (LDOS) (Zacks)
Jan-17-24 04:30PM	Leidos Appoints Dan Antal General Counsel (PR Newswire)
Jan-16-24 09:40AM	Is Leidos (LDOS) Stock Undervalued Right Now? (Zacks)
09:40AM	Has Leidos (LDOS) Outpaced Other Aerospace Stocks This Year? (Zacks)
08:00AM	Leidos Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call for Feb. 13, 2024, at 8 a.m. (ET) (PR Newswire)
Jan-08-24 01:22PM	Space Race: 3 Stocks Shooting for the Stars in 2024 (InvestorPlace)
08:08AM	Leidos (LDOS) Deploys Flight Service Voice Communications System (Zacks)
06:26AM	10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts (Insider Monkey)
Jan-05-24 10:22AM	These Two Top Stocks Are Looking To Break Out Past Aggressive Buy Points (Investor's Business Daily)

Leidos Holdings, Inc. engages in providing services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides services, solutions, and products focusing on digital modernization, mission systems and integration, command, control, computers, communications, intelligence, surveillance and reconnaissance technologies and services, maritime solutions, transformative software, analytics, intelligence analysis, mission support and logistics services, weapons systems and space systems and solutions. The Civil segment focuses on modernizing infrastructure, systems, and security. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fubini David G	Director	Mar 13 '24	Sale	127.89	7,874	1,006,969	14,696	Mar 14 06:18 PM
Dahlberg Gregory R	Director	Feb 26 '24	Option Exercise	52.70	4,788	252,328	20,195	Feb 27 04:52 PM
Hull Stephen Edward	Sector President	Feb 26 '24	Option Exercise	53.54	3,423	183,267	27,583	Feb 27 04:47 PM
Geer Noel B	Director	Feb 22 '24	Option Exercise	52.70	4,788	252,328	29,925	Feb 23 05:18 PM
May Gary Stephen	Director	Feb 21 '24	Option Exercise	52.70	4,788	252,328	16,140	Feb 22 04:59 PM
May Gary Stephen	Director	Feb 21 '24	Sale	124.49	2,745	341,721	11,352	Feb 22 04:59 PM
Porter Elizabeth A	Sector President	Feb 16 '24	Option Exercise	53.54	3,268	174,969	38,493	Feb 20 05:33 PM
Fubini David G	Director	Feb 15 '24	Option Exercise	103.97	3,892	404,662	25,902	Feb 16 04:15 PM
HOWE JERALD S JR	EVP, General Counsel	Feb 15 '24	Option Exercise	56.47	6,862	387,497	32,263	Feb 16 04:13 PM
Cage Christopher R	Chief Financial Officer	Feb 15 '24	Option Exercise	53.54	2,774	148,520	37,729	Feb 16 04:11 PM
MOHAPATRA SURYA N	Director	Nov 22 '23	Option Exercise	52.70	4,788	252,328	23,877	Nov 24 04:33 PM
MOHAPATRA SURYA N	Director	Nov 22 '23	Sale	105.83	2,401	254,102	19,089	Nov 24 04:33 PM
JOHN MIRIAM E	Director	Nov 16 '23	Sale	105.20	7,255	763,203	20,436	Nov 17 04:33 PM
Fasano Gerard A	Group President	Nov 13 '23	Option Exercise	71.52	17,650	1,262,415	96,376	Nov 15 04:29 PM
Fubini David G	Director	Nov 06 '23	Option Exercise	62.28	12,203	760,005	29,324	Nov 07 04:39 PM
Geer Noel B	Director	Nov 06 '23	Sale	103.23	2,106	217,403	29,894	Nov 08 05:04 PM
Moos James Robert	Group President	Nov 03 '23	Option Exercise	53.54	2,134	114,254	31,082	Nov 06 04:31 PM
Moos James Robert	Group President	Nov 03 '23	Sale	103.66	564	58,464	28,948	Nov 06 04:31 PM
Stevens Roy E	Group President	Nov 02 '23	Option Exercise	53.54	3,592	192,316	42,645	Nov 03 04:27 PM
Stevens Roy E	Group President	Nov 02 '23	Sale	103.20	929	95,873	39,053	Nov 03 04:27 PM
JOHN MIRIAM E	Director	Aug 10 '23	Option Exercise	39.70	5,193	206,162	29,805	Aug 14 04:41 PM
SHAPARD ROBERT S	Director	Aug 04 '23	Option Exercise	39.70	5,193	206,162	52,308	Aug 04 04:44 PM
KRAEMER HARRY M JANSEN JR	Director	Aug 04 '23	Option Exercise	39.70	5,193	206,162	89,470	Aug 07 04:38 PM
KRAEMER HARRY M JANSEN JR	Director	Aug 04 '23	Sale	96.95	3,098	300,360	84,277	Aug 07 04:38 PM
Bell Thomas Arthur	CEO	May 22 '23	Buy	78.81	6,300	496,502	6,300	May 22 04:42 PM
STALNECKER SUSAN M	Director	May 12 '23	Option Exercise	39.70	5,193	206,162	17,382	May 15 04:15 PM
May Gary Stephen	Director	May 11 '23	Option Exercise	39.70	5,193	206,162	16,545	May 12 04:30 PM
May Gary Stephen	Director	May 11 '23	Sale	78.71	2,618	206,061	11,352	May 12 04:30 PM
Dahlberg Gregory R	Director	May 05 '23	Buy	80.76	125	10,095	13,833	May 08 04:34 PM
SHAPARD ROBERT S	Director	May 04 '23	Buy	78.74	2,500	196,838	2,500	May 08 04:30 PM
SHAPARD ROBERT S	Director	May 04 '23	Buy	78.66	2,500	196,656	47,115	May 08 04:30 PM
HOWE JERALD S JR	EVP, General Counsel	May 04 '23	Buy	80.25	1,200	96,300	16,958	May 08 04:25 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

BVS

Bioventus Inc

LDOS

Leidos Holdings Inc

Upgrade your FINVIZ experience